Thus, the effect of PPP to decrease body growth (serving as a positive internal control for IGF-1R inhibition) was comparable to the reduction in compensatory kidney hypertrophy, consistent with body weight gain and compensatory kidney hypertrophy both being driven in part via the IGF-1R. Here, IGF1R is linked to cardiac hypertrophy.